Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Crescent Biopharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −6 vs. Q4 2024
- Shares held
- 30.8M
- +402.5K (+1.3%) vs. Q4 2024
- Total value
- $6.46M
- −$1.10M (−14.5%) vs. Q4 2024
- New holders
- 6
- 5 more added
- Sold out
- 12
- 7 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 2,000 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 76 | $16 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 126 | $26 | 0.00% | −10−7.4% | Reduced |
| BNP Paribas Arbitrage, SA | 481 | $101 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 787 | $165 | 0.00% | +26+3.4% | Added |
| Truvestments Capital LLC | 1,309 | $275 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,176 | $1.09K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 6,942 | $1.46K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,353 | $1.96K | 0.00% | −10,206−52.2% | Reduced |
| HRT Financial LP | 10,032 | $2.00K | 0.00% | +10,032 | New |
| Firethorn Wealth Partners, LLC | 11,700 | $2.46K | 0.00% | +11,700 | New |
| 1 North Wealth Services LLC | 12,000 | $2.52K | 0.00% | 00.0% | Unchanged |
| Pine Valley Investments Ltd Liability Co | 12,520 | $2.63K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 13,854 | $2.91K | 0.00% | −565−3.9% | Reduced |
| Two Sigma Securities, LLC | 15,740 | $3.31K | 0.00% | +15,740 | New |
| JustInvest LLC | 16,936 | $3.56K | 0.00% | −9,368−35.6% | Reduced |
| Group One Trading, L.P. | 24,425 | $5.13K | 0.00% | +1,056+4.5% | Added |
| Susquehanna International Group, LLP | 30,580 | $6.42K | 0.00% | −10,185−25.0% | Reduced |
| Virtu Financial LLC | 36,326 | $8.00K | 0.00% | +36,326 | New |
| Ieq Capital, LLC | 38,363 | $8.06K | 0.00% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 45,965 | $9.65K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 116,985 | $24.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 179,265 | $37.6K | 0.00% | 00.0% | Unchanged |
| Shay Capital LLC | 356,768 | $74.9K | 0.02% | +356,768 | New |
| Balyasny Asset Management LLC | 382,573 | $80.3K | 0.00% | +382,573 | New |
| UBS Group AG | 465,913 | $97.8K | 0.00% | +237,045+103.6% | Added |
| Geode Capital Management, LLC | 571,726 | $120.1K | 0.00% | +50,503+9.7% | Added |
| Jefferies Financial Group Inc. | 585,000 | $122.8K | 0.00% | +161,223+38.0% | Added |
| BlackRock, Inc. | 726,300 | $152.5K | 0.00% | −2,337−0.3% | Reduced |
| Wellington Management Group LLP | 1,370,297 | $287.8K | 0.00% | −43,105−3.0% | Reduced |
| Vanguard Group Inc | 2,670,208 | $560.7K | 0.00% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,000,000 | $630.0K | 0.05% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 5,091,231 | $1.07M | 0.00% | 00.0% | Unchanged |
| Logos Global Management LP | 5,400,000 | $1.13M | 0.20% | 00.0% | Unchanged |
| BVF Inc | 9,544,262 | $2.00M | 0.08% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −331,827−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −203,578−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −64,243−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −58,854−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −41,153−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −33,230−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,760−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −13,966−100.0% | Sold out |
| HBK Sorce Advisory LLC | 0 | $0 | 0.00% | −11,718−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −6,501−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −4,755−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,096−100.0% | Sold out |